Sleep apnoea syndrome today: Much done, more to do

Sleep Medicine Reviews

Volumn 7, Issue 1, 2003, Pages 3-7

  McNicholas, Walter T ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; CHILDHOOD DISEASE; EDITORIAL; HUMAN; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME;

EID: 0037313842     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1053/smrv.2002.0265     Document Type: Editorial

References (37)

1. Broadbent WH. On Cheyne-Stokes' respiration in cerebral haemorrhage. Lancet 1877; 1: 307-309.
2. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46: 85-90.
3. Young T, Peppard P. Epidemiology of obstructive sleep apnea. In: McNicholas WT, Phillipson EA (eds). Breathing Disorders in Sleep. London: WB Saunders, 2001; 31-43.
4. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001; 163: 685-689.
5. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea (State of the Art invited review). Eur Resp J 1995; 8: 1161-1178.
6. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571-1579.
7. Mezzanotte WS, Tangel DJ, White DP. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med 1996; 153: 1880-1887.
8. Hers V, Liistro G, Dury M, Collard Ph, Aubert G, Rodenstein DO. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Resp J 1997; 10: 973-976.
9. Deegan PC, Nolan P, Carey M, McNicholas WT. Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol 1996; 81: 470-479.
10. Ayappa I, Rapoport DM. The upper airway in sleep: physiology of the pharynx. Sleep Med Reviews 2003; 7: 9-33.
11. Schwartz AR, Eisele DW, Hari A, Testerman R, Erickson D, Smith PL. Electrical stimulation of the lingual musculature in obstructive sleep apnea. J Appl Physiol 1996; 81: 643-652.
12. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996; 19: 156-177.
13. Ferguson K, Ono T, Lowe A, Al-Maled S, Love L, Fleetham J. A short term controlled trial of an adjustable oral appliance versus nasal continuous positive airway pressure in the treatment of mild to moderate obstructive sleep apnea. Thorax 1997; 52: 362-368.
14. Gislason T, Benediktsdottir B. Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old. An epidemiologic study of lower limit of prevalence. Chest 1995; 107: 963-966.
15. Lipton AJ, Gozal D. Treatment of obstructive sleep apnea in children: do we really know how? Sleep Med Reviews 2003; 7: 61-80.
16. Deegan PC, McNicholas WT. Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Resp J 1996; 9: 117-124.
17. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badar S. The occurrence of sleep-disorderd breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
18. Flemons WW, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Reviews 1997; 1: 19-32.
19. Report of a Task Force of the American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-689.
20. McNicholas WT. Follow-up and outcomes of nasal CPAP therapy in patients with obstructive sleep apnoea syndrome. Monaldi Arch Chest Dis 2001; 56: 535-539.
21. Douglas NJ. Home diagnosis of the obstructive sleep apnoea/hypopnoea syndrome. Sleep Med Reviews 2003; 7: 53-59.
22. McNicholas WT. Compliance with nasal CPAP in obstructive sleep apnoea: how much is enough? (invited editorial). Eur Resp J 1997; 10: 969-970.
23. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHs). Sleep Med Reviews 2003; 7: 81-99.
24. Bonora M, Shields GI, Knuth SL, Bartlett D, Jr, St John WM. Selective depression by ethanol of upper airway respiratory motor activity in cats. Am Rev Respir Dis 1984; 130: 156-161.
25. Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794-798.
26. Partinen M, McNicholas WT. Epidemiology, morbidity and mortality of the sleep apnoea syndrome. In: McNicholas WT (ed). Respiratory Disorders During Sleep. European Respiratory Monographs. Volume 3. Copenhagen: Munsgard Press, 1998; 63-74.
27. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
28. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
29. Shahar E, Whitney CW, Redline S et al., for the Sleep Heart Health Study Research Group. Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
30. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22(2): 217-223.
31. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Resp J 2000; 16: 128-133.
32. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Reviews 2003; 7: 35-51.
33. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling J, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210.
34. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-348.
35. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166(2): 159-165.
36. Doherty LS, Swan V, McNicholas WT. Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP. Eur Resp J 2002; 20(Suppl): 294s.
37. Krieger J, McNicholas WT. Public Health and Medicolegal Implications of Sleep Apnoea: Report of an ERS Task Force. Eur Resp J 2002 (In Press).